Login / Signup

Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells.

Justine SchaefferXavier CarnecStéphanie ReynardMathieu MateoCaroline PicardNatalia PietrosemoliMarie-Agnès DilliesSylvain Baize
Published in: PLoS pathogens (2018)
Lassa virus (LASV) is responsible for a viral hemorrhagic fever in humans and the death of 3,000 to 5,000 people every year. The immune response to LASV is poorly understood, but type I interferon (IFN-I) and T-cell responses appear to be critical for the host. We studied the response of myeloid dendritic cells (mDC) to LASV, as mDCs are involved in both IFN-I production and T-cell activation. We compared the response of primary human mDCs to LASV and Mopeia virus (MOPV), which is similar to LASV, but non-pathogenic. We showed that mDCs produced substantial amounts of IFN-I in response to both LASV and MOPV. However, only MOPV-infected mDCs were able to activate T cells. More surprisingly, coculture with T cells completely inhibited the activation of LASV-infected mDCs. These differences between LASV and MOPV were mostly due to the LASV nucleoprotein, which has major immunosuppressive properties, but the glycoprotein was also involved. Overall, these results suggest that mDCs may be important for the global response to LASV and play a role in the outcome of Lassa fever.
Keyphrases
  • dendritic cells
  • immune response
  • regulatory t cells
  • sars cov
  • bone marrow
  • acute myeloid leukemia
  • solid state
  • induced pluripotent stem cells